Timely escalation of therapy is needed for disease control, as shown by the rise of HbA1c levels resulting from delaying treatment intensification [14]
Lancet 406 , 149162 (2025)
"Our study shows that patients treated for obesity with semaglutide or tirzepatide lost less weight on average in a regular clinical setting compared to what is observed in randomized clinical trials." Hamlet Gasoyan, PhD, Researcher, Cleveland Clinics Center for Value-Based Care Research Maintaining weight loss presents different challenges for each approach
Factors to consider when choosing a compounding pharmacy Besides verifying the reputation of FDA-registered facilities that compound semaglutide, consider the following when choosing a compounding pharmacy: Availability of semaglutide-specific formulations When choosing a compounding pharmacy, make sure they have semaglutide formulations
For research procurement, this supports a simple practice: compare product documentation against stable identity records and batch-specific analytical files